Post date February 21, 2023 Experience CStone Pharmaceuticals HK$392.9 million placing of new shares We advised CStone Pharmaceuticals on the placement
Post date January 18, 2023 Experience New Horizon Health HK$781.7 million top-up placement of shares We advised New Horizon Health on the top-up placement
Post date January 18, 2023 Experience Jinxin Fertility Group HK$1.17 billion top-up placement of shares The shares are listed on the Hong Kong Stock Exchange
Post date September 21, 2022 Experience Tencent Music Entertainment Group secondary listing We advised Tencent Music Entertainment Group on its secondary listing by way of introduction on the HKEX
Post date July 15, 2022 Experience Akeso HK$582 million share placement We advised Akeso in the placement of new shares
Post date June 30, 2022 Experience Li Auto $2 billion at-the-market offering This is the first at-the-market offering by a U.S.-listed issuer with a dual primary listing in Hong Kong
Post date April 28, 2021 Experience Zai Lab $857.5 million offering of American depositary shares and ordinary shares We advised Zai Lab on the concurrent offerings
Post date February 19, 2021 Experience InnoCare Pharma HK$3.04 billion share placement We advised InnoCare Pharma in the placement of new shares
Post date February 17, 2021 Experience Akeso HK$1.19 billion share placement We advised the placing agent in the placement of new shares
Post date February 2, 2021 Experience Ocumension Therapeutics HK$793.8 million top-up placement of shares We advised the placing agent in connection with the equity offering